Schedule a Free Consultation: (866) 881-0403
Schedule a Free Consultation: (866) 881-0403

Nexium Kidney Injury Lawsuit Joins Over 160 Other Cases in Mass Tort

Bradley/Grombacher, LLP • Oct 02, 2017

AstraZeneca Pharmaceuticals has been hit with a new Nexium kidney injury lawsuit alleging the over-the-counter heartburn medication is defectively designed, researched, manufactured and promoted, among other things.


Plaintiff Clarice A. alleges in the Nexium kidney injury lawsuit that the heartburn medication, known as a proton pump inhibitor or “PPI,” caused her severe injuries that include acute interstitial nephritis, acute kidney injuries, chronic kidney disease and renal failure.

The body content of your post goes here. To edit this text, click on it and delete this default text and start typing your own or paste your own from a different source.

Are Drug Makers Hiding the Risks of PPIS?

According to the Nexium lawsuit, nearly 21 million Americans used PPIs like Nexium in 2009, earning AstraZeneca $11 billion dollars that year. Previous studies show, however, that there is a causal connection between the use of PPI drugs and kidney injuries.


Recently, the Food and Drug Administration has responded to complaints about the increased risk of kidney injury from Nexium and other PPIs by requiring consistent labeling about the risk on prescribed drugs.


“The FDA noted ‘that the prescription PPI labeling should be consistent with regard to this risk’ and that ‘there is reasonable evidence of a causal association,’’ states the Nexium lawsuit.


Although over-the-counter PPIs were not required to include additional warnings, the Nexium lawsuit notes that further studies revealed a connection between these drugs and kidney injuries as well.


“In spite of their commercial success and global popularity,” says the complaint, “up to 70% of PPIs may be used inappropriately for indications or durations that were never tested or approved.”


Further complicating the problem, patients experiencing kidney injuries after taking Nexium and other PPIs report non-specific symptoms, like fatigue, nausea, and weakness, making the injury hard to diagnose.


“As the kidneys lose their ability to function properly, wastes can build to high levels in the blood resulting in numerous, serious complications ranging from nerve damage and heart disease to kidney failure and death,” says the Nexium kidney injury lawsuit.


Patients undergoing kidney complications after taking Nexium or other PPIs must be taken off the drug immediately. Kidney injuries that have progressed too far cannot be reversed.


The plaintiff alleges that AstraZeneca knew of the risks associated with PPIs and Nexium kidney injuries, but concealed this information from patients, doctors and the public to boost sales. The plaintiff also alleges that there are numerous safe alternatives for heartburn treatment that don’t cause kidney injury.


The Nexium Kidney Injury Lawsuit is Clarice A. v. AstraZeneca Pharmaceuticals LP, etc., Case No. 17-cv-07351, in the U.S. District Court, District of New Jersey.


Did You Suffer a Nexium Kidney Injury?

Drug manufacturers have a legal responsibility to keep defectively designed, manufactured, tested and labeled products off the market.

If you or a loved one suffered a kidney injury after taking Nexium, Prilosec, PrevAcid or another drug, you may have a legal claim. Defective drug lawsuits can attempt to recover compensation for medical expenses, pain and suffering, missed work, and more.


Fill out the form on this page now for a FREE case evaluation.


By Kiley L. Grombacher 21 Jun, 2023
Bradley/Grombacher LLP
Abercrombie Clothing Lawsuit Leads to $25 Million Dollar Settlement
By Bradley/Grombacher, LLP 16 May, 2023
An Abercrombie clothing lawsuit has led to a $25 million settlement over allegations that employees were required to purchase the clothing they were selling in the store.
Join Us For The 2022 Class Action Litigation Conference!
By Marcus J. Bradley 14 Sep, 2022
The program will feature an update of Pending Cases in the 9th Circuit with some SCOTUS discussion, and several important technical issues required for bringing and defending class actions.
By Bradley/Grombacher, LLP 22 Jun, 2022
Marcus Bradley is a founder and partner at Bradley/Grombacher, LLP, and focuses much of his practice on complex consumer litigation, class actions, mass torts, product liability, personal injury, and more.
By Bradley/Grombacher, LLP 21 Jun, 2022
Kiley Grombacher is a founder and partner at Bradley/Grombacher, LLP, and focuses much of her practice in complex litigation including consumer and employment class actions, product liability, and pharmaceutical mass torts.
By Bradley/Grombacher, LLP 12 May, 2022
The Harris Martin's MDL Conference is focusing on recalled infant formula and Gardasil.
By Bradley/Grombacher, LLP 12 May, 2022
The retreat is designed for attorneys and provides 6 credit hours of continuing legal education (CLE). During the event, Attorney Grombacher will be a featured speaker presenting on PAGA: What's Next After Viking River Cruises?
By Bradley/Grombacher, LLP 23 Aug, 2021
At Bradley/Grombacher, LLP, we invite you to attend HarrisMartin’s Webinar Series: Neutrogena Sunscreen Litigation. Learn more:
By Bradley/Grombacher, LLP 17 Nov, 2020
Bradley/Grombacher Law More parents are reporting the downside of school spirit – cheerleading injuries that can be catastrophic and life altering.
By Bradley/Grombacher, LLP 18 Oct, 2020
Zoosk and its parent company have been hit with a class-action lawsuit after a May 2020 data breach by a group that calls itself the "ShinyHunters" compromised 30 million users.
More Posts
Share by: